Linear extensions of hypopigmentation as a side effect of topical corticosteroid application

Gran úlcera perianal por tratamiento con pomada antihemorroidal en paciente inmunodeprimido

“…Los corticoides incluidos en la pomada que utilizaba el paciente tienen un efecto antiproliferativo sobre los fibroblastos y queratinocitos que, junto con alteraciones en la síntesis de lípidos y en el metabolismo de las proteínas, pueden producir atrofia cutánea 1 , 2 .…”

Autoimmune bullous disease in skin of color: A case series

“… 11 Importantly, potent corticosteroids can induce hypopigmentation, a side effect that can be more apparent in darker skin tones. 12 , 13 , 14 As well, because many cases of AIBD involve the scalp, dermatologists must understand the diversity of hair types and hair care practices in patients of color, which affect topical vehicle preference. 15 …”

“…11 Importantly, potent corticosteroids can induce hypopigmentation, a side effect that can be more apparent in darker skin tones. [12][13][14] As well, because many cases of AIBD involve the scalp, dermatologists must understand the diversity of hair types and hair care practices in patients of color, which affect topical vehicle preference. 15 To ensure physicians and other clinicians are competent to diagnose and treat conditions in people with skin of color, increased diversity in clinical (right) after treatment, all erosions on the back were fully healed, but significant hyperpigmented patches remained.…”

Atypical Afta Major Healing after Photodynamic Therapy

“…These medications have been applied as topical pastes, mouthrinses, and intralesional injections and systemically by the oral route. Side effects such as burning sensation at the site of application, transient taste disturbance, intermittent headaches, and rarely patchy hyperpigmentation of the oral mucosa as a result of topical immunosuppressive treatment were reported [ 6 , 7 ]. Recent reviews of the literature showed that topical treatment with natural herbal medicines seemed to benefit RAS patients by reducing ulcer size, shortening ulcer duration, and relieving pain without severe side effects, but the authors concluded that the evidence remains insufficient.…”